Core Insights - Aclarion's Nociscan product is featured in the RSNA Edition of Siemens Healthineers magazine, MAGNETOM Flash, highlighting its role in addressing chronic low back pain [1][2] - The article emphasizes the significance of MR spectroscopy (MRS) as a decision support tool for physicians in diagnosing chronic low back pain [1][3] Company Overview - Aclarion, Inc. is a healthcare technology company that utilizes biomarkers and proprietary AI algorithms to assist physicians in identifying the source of chronic low back pain [1][6] - Nociscan is the first evidence-supported SaaS platform designed to noninvasively differentiate between painful and nonpainful discs in the lumbar spine [3][6] Product Details - Nociscan quantifies chemical biomarkers associated with disc pain and provides critical insights when used alongside other diagnostic tools [3][6] - The platform operates through a cloud connection, receiving MRS data from MRI machines to analyze lumbar discs [6] Market Context - Chronic low back pain affects approximately 266 million people globally, representing a significant healthcare challenge [3]
Aclarion Announces Nociscan Featured in RSNA Edition of Siemens MAGNETOM Flash